sentences:  imipenem,
  co-amoxiclav,
  clofazimine,
  prochlorperazine,
  metronidazole.On 28 December 2012, the U.S. Food and Drug Administration (FDA) approved bedaquiline (marketed as Sirturo by Johnson & Johnson) to treat multi-drug resistant tuberculosis, the first new treatment in 40 years.Sirturo is to be used in a combination therapy for patients who have failed standard treatment and have no other options.